DGAP-News: Alphaform AG / Key word(s): Quarter Results Alphaform AG: Preliminary first quarter 2014: Alphaform on track 29.04.2014 / 12:53 --------------------------------------------------------------------- Press release Preliminary first quarter 2014: Alphaform on track Revenue increases by 14.4% to EUR 7.5 million compared with same period of previous year Operating result of EUR -0.3 million affected by restructuring costs Forecast for year as a whole confirmed Feldkirchen, 29 April 2014 - Alphaform AG, a service provider for industrial 3-D printing, is on course to achieve its announced realignment. For the first quarter of 2014, the company reported an increase in revenue of around 14.4% to EUR 7.5 million (first quarter of 2013: EUR 6.6 million). This development was supported by a stable economy during the reporting period. The profit/loss before taxes (operating result) was EUR -0.3 million in the first quarter of 2014, after a balanced result in the same quarter of the previous year. The negative operating result was due primarily to restructuring costs, including consultancy costs and non-recurring expenses for the capital increase. This is also reflected in EBITDA, which amounted to EUR 0.0 million in the first quarter of 2014. In the same period of the previous year, this was plus EUR 0.3 million. Cash flow from operating activities in the first three months of business year 2014 was EUR -1.1 million, compared with EUR -0.3 million in the reporting period of the previous year. This was also mainly due to restructuring costs. The gross margin was increased slightly in the first quarter of 2014 by 1.2% to 68.8 percentage points. In the same period of the previous year, this was 67.6 percentage points. Capital increase and change of Management Board In February 2014, Alphaform AG implemented a capital increase. This brought the company funds of around EUR 1.8 million. In addition to the capital increase, on 25 February 2014 the core shareholders granted Alphaform AG a loan of EUR 1.5 million. This is sufficient to finance our extensive Excellence Programme for process improvement and modernisation across the whole of business year 2014. On 28 March 2014, Dr Hanns-Dieter Aberle, the new chairman, took over from his predecessor. The change took place on mutually agreed terms with the Supervisory Board. "In the first quarter of 2014, we have achieved our realignment plan," emphasises Aberle. "We are on the right track and must now pursue this consistently." Good development in the operating segments Alphaform's Feldkirchen location, which specialises in plastic and model making, recorded a significant rise in revenue of 14%, from EUR 4.2 million in the first quarter of 2013 to EUR 4.8 million in the first quarter of 2014. Two new, highly productive stereolithography machines were ordered and put into operation in April, earlier than expected. Alphaform-Claho, the metal and rapid tooling subsidiary in Eschenlohe, increased its revenue in the first quarter of 2014 from EUR 0.8 million to a satisfactory EUR 1.1 million. The sales measures initiated last year have already begun to bear fruit at MediMet, the precision casting subsidiary in Stade. The good level of incoming orders in the fourth quarter of 2013 reached production in early 2014 and helped to boost revenue. MediMet's revenue in the first quarter of 2014 amounted to EUR 1.9 million, slightly above that in the same quarter of the previous year. Alphaform's subsidiaries in Scandinavia and the UK stabilised at a high level. Forecast for financial year 2014 confirmed Alphaform is forecasting revenue of around EUR 30 million for 2014 and a significant earnings improvement as against the previous year. However, given the necessary restructuring expenses, the Management Board anticipates a net loss of EUR -1 million for 2014, primarily due to restructuring costs. Key figures of the Alphaform Group EUR million 1st quarter 2014 2013 Change in % Revenue 7.513 6.567 14.4 EBITDA 0.017 0.348 -95.1 Operating result -0.297 0.053 - Result after taxes -0.398 -0.036 - Earnings per share -0.07 EUR -0.01 EUR - Total assets as of 31 March 8.055 6.626 21.6 Equity as of 31 March 17.623 15.765 11.8 Equity ratio (percent) 45.7% 42.0% 8.7 Cash and cash equivalents and securities as 1.155 1.152 0.3 of 31 March Group employees as of 31 March 234 231 1.3 About Alphaform Alphaform AG, based in Feldkirchen near Munich was founded in 1996. The company belongs to the European market leaders in the production of complex components means additive manufacturing, which are often grouped together under the term "3D printing". An important mainstay of the segment 3D Printing and Additive Manufacturing is the production of series close prototypes, particularly for the automotive and capital goods industries. The Medical Division of Alphaform has a leading position throughout Europe in manufacturing and processing orthopaedic implants and instruments. The shares of Alphaform are listed in the Prime Standard Segment of the Frankfurt Stock Exchange (FWB) under the abbreviation ATF. The core competence of Alphaform lies in its extensive application know-how for processes and materials for the additive production of complex prototypes, tools, individual components and small series made of plastic and metal. The company's activity is focused on the orthopaedic and medical technology, automotive, aviation and aerospace industries. The subsidiaries of Alphaform are located in Germany, Finland, Sweden and the UK. Contact: Dr. Hanns-Dieter Aberle CEO Tel.: +49 89 905002 35 ALPHAFORM AG Fax: +49 89 905002 1035 Kapellenstraße 10 e-mail: [email protected] 85622 Feldkirchen Internet: www.alphaform.de End of Corporate News --------------------------------------------------------------------- 29.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Alphaform AG Kapellenstraße 10 85622 Feldkirchen Germany Phone: +49 (0)89 905002 - 0 Fax: +49 (0)89 905002 - 90 E-mail: [email protected] Internet: www.alphaform.de ISIN: DE0005487953 WKN: 548795 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 265355 29.04.2014